Inspire Medical Systems (STU:2DR) Common Stock: €0.0 Mil (As of Mar. 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
55 GF Score
Price €43.00
GF Value €188.74
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Common Stock?

Inspire Medical Systems STU:2DR -1.83% 55 Common Stock is €0.0 Mil as of Mar. 2026. GuruFocus rates STU:2DR with a GF Score™ of 55/100 and a GF Value™ of €188.74 (Possible Value Trap). The stock has 7 warning signs investors should review.

Inspire Medical Systems's quarterly common stock stayed the same from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€0.0 Mil) and stayed the same from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€0.0 Mil).

Inspire Medical Systems's annual common stock increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then declined from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€0.0 Mil).

Inspire Medical Systems Common Stock Historical Data

* Premium members only.

The historical data trend for Inspire Medical Systems's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems Common Stock Chart

Inspire Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.03 0.03 0.03

Inspire Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.03
STU:2DR
55GF Score
Inspire Medical Systems Inc STU:2DR
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.0 Mil mean?
Inspire Medical Systems (STU:2DR) has a Common Stock of €0.0 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Inspire Medical Systems and its competitors.
Is Inspire Medical Systems' Common Stock too high?
Inspire Medical Systems' current Common Stock is €0.0 Mil. Overall, Inspire Medical Systems has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Common Stock compare to ENOV and PRCT?
Inspire Medical Systems' Common Stock of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Inspire Medical Systems and its competitors. Inspire Medical Systems's current Common Stock is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €188.74, compared to a current price of €43.00 — trading 77.2% below its estimated fair value. The current Common Stock is €0.0 Mil. Inspire Medical Systems' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Common Stock is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €43.00 is trading 77.2% below its estimated GF Value™ of €188.74. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Common Stock: €0.0 Mil
  • GF Value™: €188.74 vs. price of €43.00 (77.2% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
55GF Score

Get the complete analysis for STU:2DR

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.00
Price
€188.74
GF Value